Cumulative effects of raloxifene on the incidence of breast cancer over 8 years in postmenopausal women with osteoporosis.

被引：0
|
作者：
Mershon, J.
Yea, A.
Qu, Y.
Wong, M.
Mitchell, B.
Vogel, V.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [21] Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis
    Burshell, Alan L.
    Song, Jingli
    Dowsett, Sherie A.
    Mershon, John L.
    Delmas, Pierre D.
    Secrest, Roberta J.
    Cauley, Jane A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 807 - 813
  • [22] A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment
    Lee, Jihyoun
    Lee, Ji Sung
    Lee, Jong Eun
    Kim, Zisun
    Han, Sun Wook
    Hur, Sung Mo
    Choi, Young Jin
    Park, Sungmin
    JOURNAL OF BREAST CANCER, 2021, 24 (03) : 280 - 288
  • [23] The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial
    Shand, B
    Gilchrist, N
    Blackwell, T
    March, R
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2002, 26 (04) : 249 - 255
  • [24] Raloxifene (Evista) for breast cancer prevention in postmenopausal women
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1234): : 37 - 37
  • [25] Occurrence of benign breast conditions, breast symptoms, and breast biopsies in postmenopausal women treated with placebo or raloxifene for 8 years
    Mershon, John
    Natanegara, Fanni
    Wong, Mayme
    Mitchell, Beth
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (06): : 1006 - 1006
  • [26] Effect of raloxifene on invasive breast cancer incidence in postmenopausal women from the United States and Canada
    Mershon, John
    Disch, Damon
    Dowsett, Sherie
    Martino, Silvana
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 81S - 82S
  • [27] Effects of discontinuation of teriparatide treatment on cortical bone in postmenopausal women with osteoporosis.
    Bogado, CE
    Mango, A
    Sato, M
    Zanchetta, JR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S54 - S54
  • [28] Effects of raloxifene treatment during one year on OPG-RANK ligand system in postmenopausal osteoporosis.
    Fernández-García, D
    Mezquita-Raya, P
    Reyes-García, R
    de la Higuera, M
    Alonso, G
    García, AM
    Ruiz-Requena, M
    Muñoz-Torres, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S408 - S408
  • [29] A Review of the Prevention of Invasive Breast Cancer with Raloxifene in Postmenopausal Women
    Arango, Belisario A.
    Castrellon, Aurelio B.
    Santos, Edgardo S.
    Gluck, Stefan
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1173 - 1178
  • [30] Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women
    Provinciali, Nicoletta
    Suen, Chen
    Dunn, Barbara K.
    DeCensi, Andrea
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1263 - 1272
12345